2101625-18-5: Tetraxetan Related Compound A
Tetraxetan Related Compound A (CAS No: 2101625-18-5) Or 2,2?,2?-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid, Tetraxetan is used as a complexing agent, Its complexes have medical applications as contrast agents and cancer treatments.
Additional information on CAS 2101625-18-5
Catalogue No.
VE008438
CAS No.
2101625-18-5
Molecular Formula
C18H32N4O8
Molecular Weight
432.47 g/mol
Parent drug
Tetraxetan
IUPAC Name
2, 2′, 2″-[10-(2-Ethoxy-2-oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl]triacetic acid
Synonyms
N/A
References
Sci-Hub, Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer : A phase 1 trial, 10.1002/cncr.27592. (2012). Retrieved December 27, 2021, from Sci-hub.ee website: https://sci-hub.ee/10.1002/cncr.27592
Status
In-stock
